The China neurology devices market size is projected to expand at a CAGR of 5.22% during the forecast period. Growth of the market is attributed to the increasing neurological diseases, rising investment in neuroscience equipment by private agents, and the growth of R&D in neurotherapies.
Neurological equipment helps in early detection of various neurological diseases to help prevent Alzheimer’s disease, major depression, spinal cord injury, acute ischemic stroke, traumatic brain injury, and other diseases. These devices represent minimally invasive based technology. Neurological devices are usually used in complex neurological cases, such as acute ischemic stroke, and are recommended for minimally invasive treatment. Compared to drug thrombolysis, these devices have potential advantages, such as faster recanalization and lower bleeding risk.
The Covid-19 pandemic affected the demand and supply of China neurology devices market. Lockdown across the globe, supply chain disorders, and oscillating supply of raw materials forced manufacturers to shut down production leading to unfortunate decline in market growth. Launch of vaccines to combat the Covid-19 pandemic is expected to contribute to the market growth over the forecast period.
The report on the China neurology devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
China Neurology Devices Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2021 |
Historic Data |
2019–2020 |
Forecast Period |
2021–2028 |
Segmentation |
Types (Cerebrospinal Fluid Management Device, Interventional Neurology Device, Neurosurgery Device, Neurostimulation Device, and Others), End-users (Hospitals, Ambulatory Surgery Centers, and Neurology Clinics) |
Country Scope |
China |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report |
Abbott Laboratories; B. Braun Melsungen AG; Boston Scientific Corporation; Johnson and Johnson; Medtronic PLC; MicroPort Scientific; Nihon Kohden Corporation; Smith & Nephew plc; and Stryker Corporation. |
Based on types, the China neurology devices market is segregated into cerebrospinal fluid management device, interventional neurology device, neurosurgery device, neurostimulation device, and others. The cerebrospinal fluid management device segment is anticipated to expand at a rapid pace. The CSF imbalance can cause an increase in intracranial pressure (ICP), which can cause a variety of symptoms. In recent years, there has been tremendous development in the diagnosis and treatment of neurological illnesses, which is projected to drive market the market during forecast period.
Based on end users, the China neurology devices market is segregated into hospitals, ambulatory surgery centers, and neurology clinics. The hospital segment accounts for a significant share of the market. Growth of the market is attributed to increasing prevalence of neurological disorders and rapid advancement in neurology devices. On the other hand, the ambulatory surgery centers segment is anticipated to expand at a rapid pace during the forecast period due to increasing inclination of patients for minimally invasive medical procedures, increasing number of outpatient surgery centers in developed countries, and convenience of programming in these centers, professional clinical staff, increased productivity, and increased safety and efficiency.
The China neurology devices market is segmented on the basis of
Major players competing in the China neurology devices market include Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Johnson and Johnson, Medtronic PLC, MicroPort Scientific, Nihon Kohden Corporation, Smith & Nephew plc, and Stryker Corporation.
Some of these players are using several market strategies including mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase their market shares.
The China neurology devices market is segmented on the basis of
Major players competing in the China neurology devices market include Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Johnson and Johnson, Medtronic PLC, MicroPort Scientific, Nihon Kohden Corporation, Smith & Nephew plc, and Stryker Corporation.
Some of these players are using several market strategies including mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase their market shares.
Some other reports from this category!